Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_assertion type Assertion NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_head.
- NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_assertion description "[MAL methylation status may therefore serve as a marker of platinum sensitivity while MAL protein may be a target for development of novel therapies aimed at enhancing sensitivity to platinum-based drugs in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_provenance.
- NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_assertion evidence source_evidence_literature NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_provenance.
- NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_assertion SIO_000772 19642140 NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_provenance.
- NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_assertion wasDerivedFrom befree-20140225 NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_provenance.
- NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_assertion wasGeneratedBy ECO_0000203 NP516475.RA9x0JbC91M42DYTcuuwY5TxiCMy61aCpymLXMKHJFQeE130_provenance.